Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids

Glycoconjugate Journal

Volumn 26, Issue 9, 2009, Pages 1171-1180

  Nilsson, Jonas ^a   Rydell, Gustaf E ^a   Le Pendu, Jacques ^b   Larson, Göran ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

ABH antigen; Glycosphingolipid; Norovirus; Secretor; Virus like particle

Indexed keywords

ANTIGEN; BENZOIC ACID DERIVATIVE; GLYCOSPHINGOLIPID; IODINE 125; N SUCCINIMIDYL 3 TRIBUTYLSTANNYL BENZOATE; UNCLASSIFIED DRUG; FUCOSE; RADIOACTIVE IODINE;

ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP O; CONTROLLED STUDY; ERYTHROCYTE; FUCOSYLATION; HUMAN; ISOTOPE LABELING; NOROVIRUS; PRECURSOR; PRIORITY JOURNAL; PROTEIN BINDING; THIN LAYER CHROMATOGRAPHY; VIRUS LIKE AGENT; CARBOHYDRATE ANALYSIS; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; VIRION;

NOROVIRUS; NORWALK VIRUS;

ABO BLOOD-GROUP SYSTEM; CARBOHYDRATE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ERYTHROCYTES; FUCOSE; GLYCOSPHINGOLIPIDS; HUMANS; IODINE RADIOISOTOPES; LEWIS BLOOD-GROUP SYSTEM; MOLECULAR SEQUENCE DATA; NORWALK VIRUS; VIRION;

EID: 77649262827     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-009-9237-x     Document Type: Article

References (59)

1. Hutson, A.M., Atmar, R.L., Estes, M.K.: Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 12, 279-287 (2004)
2. Tan, M., Jiang, X.: Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol. 13, 285-293 (2005)
3. Olofsson, S., Bergstrom, T.: Glycoconjugate glycans as viral receptors. Ann. Med. 37, 154-172 (2005)
4. Straub, T.M., HönerzuBentrup, K., Orosz-Coghlan, P., Dohnalkova, A., Mayer, B.K., Bartholomew, R.A., Valdez, C.O., Bruckner-Lea, C.J., Gerba, C.P., Abbaszadegan, M., Nickerson, C.A.: In vitro cell culture infectivity assay for human noroviruses. Emerg. Infect. Dis 13, 396-403 (2007)
5. Jiang, X., Wang, M., Graham, D.Y., Estes, M.K.: Expression, selfassembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66, 6527-6532 (1992)
6. Green, K.Y., Lew, J.F., Jiang, X., Kapikian, A.Z., Estes, M.K.: Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31, 2185-2191 (1993)
7. Harrington, P.R., Vinje, J., Moe, C.L., Baric, R.S.: Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol. 78, 3035-3045 (2004)
8. Thorven, M., Grahn, A., Hedlund, K.O., Johansson, H., Wahlfrid, C., Larson, G., Svensson, L.: A homozygous nonsense mutation (428G->t;A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol. 79, 15351-15355 (2005)
9. Kapikian, A.Z.: The discovery of the 27-nm Norwalk virus: an historic perspective. J. Infect. Dis. 181(Suppl 2), S295-302 (2000)
10. Prasad, B.V., Hardy, M.E., Dokland, T., Bella, J., Rossmann, M. G., Estes, M.K.: X-ray crystallographic structure of the Norwalk virus capsid. Science 286, 287-290 (1999)
11. Bu, W., Mamedova, A., Tan, M., Xia, M., Jiang, X., Hegde, R.S.: Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 82, 5340-5347 (2008)
12. Choi, J.M., Hutson, A.M., Estes, M.K., Prasad, B.V.: Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci USA 105, 9175-9180 (2008)
13. Ravn, V., Dabelsteen, E.: Tissue distribution of histo-blood group antigens. Acta Pathol. Microbiol. Scand. 108, 1-28 (2000)
14. Le Pendu, J., Ruvoen-Clouet, N., Kindberg, E., Svensson, L.: Mendelian resistance to human norovirus infections. Semin. Immunol. 18, 375-386 (2006)
15. Harrington, P.R., Lindesmith, L., Yount, B., Moe, C.L., Baric, R.S.: Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76, 12335-12343 (2002)
16. Huang, P., Farkas, T., Marionneau, S., Zhong, W., Ruvoen-Clouet, N., Morrow, A.L., Altaye, M., Pickering, L.K., Newburg, D.S., LePendu, J., Jiang, X.: Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 188, 19-31 (2003)
17. Lindesmith, L., Moe, C., Marionneau, S., Ruvoen, N., Jiang, X., Lindblad, L., Stewart, P., LePendu, J., Baric, R.: Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548-553 (2003)
18. Marionneau, S., Ruvoen, N., Le Moullac-Vaidye, B., Clement, M., Cailleau-Thomas, A., Ruiz-Palacois, G., Huang, P., Jiang, X., Le Pendu, J.: Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 122, 1967-1977 (2002)
19. Marionneau, S., Airaud, F., Bovin, N.V., Le Pendu, J., Ruvoen-Clouet, N.: Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J. Infect. Dis. 192, 1071-1077 (2005)
20. Thomsson, K.A., Prakobphol, A., Leffler, H., Reddy, M.S., Levine, M.J., Fisher, S.J., Hansson, G.C.: The salivary mucin MG1 (MUC5B) carries a repertoire of unique oligosaccharides that is large and diverse. Glycobiology 12, 1-14 (2002)
21. Hutson, A.M., Atmar, R.L., Marcus, D.M., Estes, M.K.: Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J. Virol. 77, 405-415 (2003)
22. Huang, P., Farkas, T., Zhong, W., Tan, M., Thornton, S., Morrow, A.L., Jiang, X.: Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79, 6714-6722 (2005)
23. Henry, S., Jovall, P.A., Ghardashkhani, S., Elmgren, A., Martinsson, T., Larson, G., Samuelsson, B.: Structural and immunochemical identification of Le(a), Le(b), H type 1, and related glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor. Glycoconj. J. 14, 209-223 (1997)
24. Holgersson, J., Stromberg, N., Breimer, M.E.: Glycolipids of human large-intestine-difference in glycolipid expression related to anatomical localization, epithelial non-epithelial tissue and the Abo, Le and Se phenotypes of the donors. Biochimie 70, 1565-1574 (1988)
25. Karlsson, K.A., Larson, G.: Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a-b+) secretor. J. Biol. Chem 256, 3512-3524 (1981)
26. Brown, K.E., Anderson, S.M., Young, N.S.: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262, 114-117 (1993)
27. Brown, K.E., Hibbs, J.R., Gallinella, G., Anderson, S.M., Lehman, E.D., McCarthy, P., Young, N.S.: Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 330, 1192-1196 (1994)
28. Tsai, B., Gilbert, J.M., Stehle, T., Lencer, W., Benjamin, T.L., Rapoport, T.A.: Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22, 4346-4355 (2003)
29. Karlsson, K.A., Stromberg, N.: Overlay and solid-phase analysis of glycolipid receptors for bacteria and viruses. Methods Enzymol. 138, 220-232 (1987)
30. Garg, P.K., Garg, S., Zalutsky, M.R.: N-Succinimidyl 4-methyl-3- (tri-n-butylstannyl) benzoate: Synthesis and potential utility for the radioiodination of monoclonal antibodies. Nucl. Med. Biol. 20, 379-387 (1993)
31. Lindegren, S., Andersson, H., Back, T., Jacobsson, L., Karlsson, B., Skarnemark, G.: High-efficiency astatination of antibodies using Niodosuccinimide as the oxidising agent in labelling ofN-succinimidyl 3-(trimethylstannyl) benzoate. Nucl. Med. Biol. 28, 33-39 (2001)
32. Karlsson, K.A.: Preparation of total nonacid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies. Methods Enzymol. 138, 212-220 (1987)
33. Angstrom, J., Falk, K.E., Karlsson, K.A., Larson, G.: Chemical fingerprinting of non-acid glycosphingolipids in meconium of a human individual of blood group B Le(a-b+) and secretor. Biochim. Biophys. Acta 712, 274-282 (1982)
34. McKibbin, J.M., Spencer, W.A., Smith, E.L., Mansson, J.E., Karlsson, K.A., Samuelsson, B.E., Li, Y.T., Li, S.C.: Lewis blood group fucolipids and their isomers from human and canine intestine. J. Biol. Chem. 257, 755-760 (1982)
35. Stahl, E.: Dünnschichtchromatographie, p 817. Springer, Berlin (1967)
36. Procter, J., Crawford, J., Bunce, M., Welsh, K.I.: A rapid molecular method (polymerase chain reaction with sequencespecific primers) to genotype for ABO blood group and secretor status and its potential for organ transplants. Tissue Antigens 50, 475-483 (1997)
37. Grahn, A., Elmgren, A., Aberg, L., Svensson, L., Jansson, P.A., Lönnroth, P., Larson, G.: Determination of Lewis FUT3 gene mutations by PCR using sequence-specific primers enables efficient genotyping of clinical samples. Hum. Mutat. 18, 358-359 (2001)
38. Dabrowski, J., Hanfland, P., Egge, H.: Structural analysis of glycosphinoglipids by high-resolution 1H nuclear magnetic resonance spectroscopy. Biochemistry 19, 5652-5658 (1980)
39. Clausen, H., Levery, S.B., McKibbin, J.M., Hakomori, S.: Blood group A determinants with mono-and difucosyl type 1 chain in human erythrocyte membranes. Biochemistry 24, 3578-3586 (1985)
40. Clausen, H., Levery, S.B., Kannagi, R., Hakomori, S.: Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization. J. Biol. Chem. 261, 1380-1387 (1986)
41. Angstrom, J., Larsson, T., Hansson, G.C., Karlsson, K.A., Henry, S.: Default biosynthesis pathway for blood group-related glycolipids in human small intestine as defined by structural identification of linear and branched glycosylceramides in a group O Le (a-b-) nonsecretor. Glycobiology 14, 1-12 (2004)
42. Ausar, S.F., Foubert, T.R., Hudson, M.H., Vedvick, T.S., Middaugh, C.R.: Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J. Biol. Chem. 281, 19478-19488 (2006)
43. Hansson, G.C.: Structural aspects of blood group glycosphingolipids in the gastrointestinal tract. Adv. Exp. Med. Biol. 228, 465-494 (1988)
44. Rydell, G.E., Nilsson, J., Rodriguez, J., Ruvoën-Clouet, N., Svensson, L., Le Pendu, J., Larson, G.: Human noroviruses recognize Sialyl Lewis x neoglycoprotein. Glycobiology 19, 309-320 (2009)
45. Shirato, H., Ogawa, S., Ito, H., Sato, T., Kameyama, A., Narimatsu, H., Xiaofan, Z., Miyamura, T., Wakita, T., Ishii, K., Takeda, N.: Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J. Virol. 82, 10756-10767 (2008)
46. Clausen, H., Watanabe, K., Kannagi, R., Levery, S.B., Nudelman, E., Arao-Tomono, Y., Hakomori, S.: Blood group A glycolipid (Ax) with globo-series structure which is specific for blood group A1 erythrocytes: one of the chemical bases for A1 and A2 distinction. Biochem. Biophys. Res. Commun. 124, 523-529 (1984)
47. Svensson, L., Rydberg, L., De Mattos, L., Henry, S.: Blood group A 1and A 2revisited: an immunochemical analysis. Vox Sang. 96, 56-61 (2009)
48. Clausen, H., Levery, S.B., Nudelman, E., Baldwin, M., Hakomori, S.: Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes. Biochemistry 25, 7075-7085 (1986)
49. Hanfland, P., Kordowicz, M., Niermann, H., Egge, H., Dabrowski, U., Peter-Katalinic, J., Dabrowski, J.: Purification and structures of branched blood-group-B-active glycosphingolipids from human erythrocyte membranes. Eur. J. Biochem. 145, 531-542 (1984)
50. Hutson, A.M., Airaud, F., LePendu, J., Estes, M.K., Atmar, R.L.: Norwalk virus infection associates with secretor status genotyped from sera. J. Med. Virol. 77, 116-120 (2005)
51. Smith, A.E., Lilie, H., Helenius, A.: Ganglioside-dependent cell attachment and endocytosis of murine polyomavirus-like particles. FEBS Lett. 555, 199-203 (2003)
52. Delorme, C., Brussow, H., Sidoti, J., Roche, N., Karlsson, K.A., Neeser, J.R., Teneberg, S.: Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J. Virol. 75, 2276-2287 (2001)
53. Fraker, P.J., Speck, J.C.: Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α, 6α-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80, 849-857 (1978)
54. Bolton, A.E., Hunter, W.M.: The labeling of proteins to high specific radioactivites by conjugation to a 125I-containing acylating agent. Biochem. J. 133, 529-539 (1973)
55. Tan, M., Jin, M., Xie, H., Duan, Z., Jiang, X., Fang, Z.: Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J. Med. Virol. 80, 1296-1301 (2008)
56. Kindberg, E., Akerlind, B., Johnsen, C., Knudsen, J.D., Heltberg, O., Larson, G., Bottiger, B., Svensson, L.: Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark. J. Clin. Microbiol. 45, 2720-2722 (2007)
57. Larsson, M.M., Rydell, G.E., Grahn, A., Rodriguez-Diaz, J., Akerlind, B., Hutson, A.M., Estes, M.K., Larson, G., Svensson, L.: Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J. Infect. Dis. 194, 1422-1427 (2006)
58. White, L.J., Ball, J.M., Hardy, M.E., Tanaka, T.N., Kitamoto, N., Estes, M.K.: Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J. Virol. 70, 6589-6597 (1996)
59. Mollicone, R., Cailleau, A., Oriol, R.: Molecular genetics of H, Se, Lewis and other fucosyltransferase genes. Transfus. Clin. Biol. 2, 235-242 (1995)